Neuren Pharmaceuticals Limited (ASX:NEU)

Australia · Delayed Price · Currency is AUD

23.44

-0.20 (-0.85%)

Aug 12, 2026, 1:24 PM AEST

Neuren Pharmaceuticals Financials Overview

Financials in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	64.65	64.65	216.83	231.94	15.42	3.2
Revenue Growth	-70.46%	-70.19%	-6.51%	1404.46%	382.23%	345.89%
Gross Profit	28.26	28.26	183.86	205.19	2.71	-6.32
Operating Income	22.04	22.04	179.16	199.25	-0.73	-8.23
Net Income	30.44	30.44	142.04	157.08	0.18	-7.79
Earnings Per Share	0.23	0.23	1.09	1.20	0.00	-0.07
EPS Growth	-79.72%	-78.57%	-9.58%	120020.00%	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Commercial Products	64.63	64.63	213.24	231.93	14.55
Corporate	0.02	0.02	3.59	0.02	-
Total	64.65	64.65	216.83	231.94	14.55

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Cash (Debt)	296.12	296.12	222.24	228.54	40.18	36.78
Net Cash Growth	-1.14%	33.24%	-2.76%	468.79%	9.23%	52.07%
Net Cash Per Share	2.26	2.26	1.70	1.75	0.31	0.31
Cash & Investments	296.12	296.12	222.24	228.54	40.18	36.78

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	125.42	125.42	-11.27	184.93	3.6	-9.97
Capital Expenditures	-0.04	-0.04	-0.01	-0.04	-0.02	-0.01
Free Cash Flow	125.39	125.39	-11.28	184.89	3.58	-9.98
Free Cash Flow Growth	-8.85%	-	-	5064.39%	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	43.71%	43.71%	84.80%	88.47%	17.55%	-197.65%
Operating Margin	34.09%	34.09%	82.63%	85.90%	-4.75%	-257.52%
Pretax Margin	60.22%	60.22%	84.37%	88.44%	1.19%	-243.79%
Profit Margin	47.08%	47.08%	65.51%	67.72%	1.19%	-243.79%
FCF Margin	193.95%	193.95%	-5.20%	79.71%	23.22%	-312.17%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	101.59	77.43	11.18	20.23	5442.54	-
Forward PE	64.51	55.42	19.45	32.20	19.55	135.13
P/FCF Ratio	23.90	18.80	-	17.19	279.73	-
PS Ratio	46.36	36.46	7.32	13.70	64.96	148.54